New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 21, 2012
16:39 EDTZLC, VVUS, STJ, SQNM, CRM, TLYS, AETOn The Fly: Closing Wrap
Stocks on Wall Street were higher on the day, the last full trading session of the week ahead of Thursday's holiday and Friday's half day. Jobless data that was in-line with expectations did little to move the markets before the open, but the markets slowly moved higher through the session, although volume remained light. Just after midday, news crossed that a cease fire between Israel and Hamas had been reached, tempering fears that the conflict could escalate to involve other players in the region and have broader economic impacts... ECONOMIC EVENTS: In the U.S., initial jobless claims fell to 410,000, which was in-line with forecasts. Markit's "flash" November flash PMI rose to 52.4 from 51.0 in October. The final November reading of the University of Michigan Sentiment index slipped to 82.7 from its 84.9 preliminary reading. The leading indicators edged up 0.2% in October to 96.0 from 95.8 in September. In Europe, the region's finance ministers and the IMF were unable to reach a bailout agreement for Greece and will meet again on Monday with an eye on resolving the remaining disagreements. In Asia, Japanese exports fell 6.5% in October, lower than expectations for a 4.9% decline... COMPANY NEWS: Salesforce.com's (CRM) Q3 results beat on the top and bottom lines and RW Baird and Wells Fargo reiterated their Outperform ratings on the stock following the report, and shares of Salesforce.com traded higher on the session, settling up $12.88, or 8.83%, to $158.78... MAJOR MOVERS: Among notable gainers were shares of VIVUS (VVUS), up $1.38, or 13.33%, to $11.73 after Aetna (AET) posted a policy revision that expands coverage of the company's weight-loss drug Qsymia. Also higher were shares of Sequenom (SQNM), up 56c, or 15.18%, to $4.25 after a committee of the American College of Obstetricians and Gynecologists recommended that cell-free fetal DNA testing be offered to certain at-risk patients. Among the noteworthy were shares of Zale (ZLC), down over $2.23, or 29.97%, to $5.21, and Tilly's (TLYS), down $2.69, or 17.18%, to $12.97 after reporting earnings. Also lower were shares of St. Jude Medical (STJ), which fell $4.34, or 12.15%,to $31.37 after an FDA inspection report cited serious flaws in its oversight of design changes in its Durata line of defibrillator leads... INDICES The Dow was up 48.38, or 0.38%, to 12,836.89; the S&P 500 was up 3.22, or 0.23%, to 1,391.03;the Nasdaq was up 9.87, or 0.34%, to 2,926.55.
News For CRM;VVUS;AET;SQNM;ZLC;TLYS;STJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 17, 2014
08:19 EDTCRMSalesforce.com announces launch of Salesforce Files Connect
Subscribe for More Information
December 16, 2014
13:19 EDTCRMResearch firm sees Amazon spinning off AWS in 2015, CNBC reports
Subscribe for More Information
December 15, 2014
07:35 EDTVVUSApricus Biosciences appoints Barbara Troupin, M.D. as Chief Medical Officer
Subscribe for More Information
07:33 EDTCRMSusquehanna to hold a tour
Subscribe for More Information
December 12, 2014
13:52 EDTAETLeerink healthcare services analyst holds an analyst/industry conference call
Subscribe for More Information
08:46 EDTAETAetna price target raised to $103 from $92 at Credit Suisse
Credit Suisse raised Outperform rated Aetna's price target to $103 based on updated guidance and longer term growth opportunities.
08:03 EDTAETAetna 2015 EPS guidance cautious, says Wells Fargo
Subscribe for More Information
06:36 EDTCRMSalesforce.com resumed with an Overweight at Piper Jaffray
Price target lowered to $64 from $74.
December 11, 2014
08:50 EDTAETAetna sees operating EPS highest in 1Q15
Subscribe for More Information
05:23 EDTSTJSt. Jude Medical announces CE Mark approval of Quadra Allure MP CRT-P
Subscribe for More Information
December 10, 2014
17:04 EDTAETAetna sees FY15 operating EPS at least $6.90, consensus $7.17
Sees FY15 operating revenue at least $62B, consensus $61.68B. Guidance to be confirmed at investor conference in New York on December 11.
17:02 EDTAETAetna backs FY14 operating EPS $6.60-$6.70, consensus $6.68
Subscribe for More Information
14:45 EDTAETDeal would block payments to health insurance companies, The Hill says
Subscribe for More Information
13:10 EDTCRMSalesforce.com management to meet with FBR Capital
Subscribe for More Information
10:53 EDTCRMSalesforce.com calls active on activist investor speculation
Subscribe for More Information
10:05 EDTCRMRumor: Salesforce.com moves up on activist investor speculation
December 9, 2014
14:22 EDTAETAetna updates clinical policy for H.P. Acthar Gel
Subscribe for More Information
06:00 EDTCRMSalesforce.com names YouTube CEO Susan Wojcicki to board
Subscribe for More Information
December 8, 2014
07:28 EDTCRMFBN Securities to hold a bus tour
Subscribe for More Information
December 5, 2014
06:21 EDTAETAetna to host investor meeting
Investor meeting to be held on December 11 at 8:30 am. Webcast Link
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use